Cargando…

Human S100A8 and S100A9 activate phagocytes via Toll-like receptor 4 independent of RAGE

Detalles Bibliográficos
Autores principales:	Vogl, T, Wolf, M, Petersen, B, Ehrhardt, C, van Zoelen, MAD, Foell, D, Roth, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4291901/ http://dx.doi.org/10.1186/1478-811X-7-S1-A91

Ejemplares similares

Crosslinking of microtubules and actin filaments by S100A8/S100A9
por: Wolf, M, et al.
Publicado: (2009)

OR6-001 - S100A12 as pro-inflammatory TLR4 ligand
por: Kessel, C, et al.
Publicado: (2013)

PReS-FINAL-2340: A pathogenic role for S100A8/A9 in experimental autoimmune arthritis
por: Kessel, C, et al.
Publicado: (2013)

RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis
por: Turovskaya, Olga, et al.
Publicado: (2008)

The roles of toll-like receptor 4, CD33, CD68, CD69, or CD147/EMMPRIN for monocyte activation by the DAMP S100A8/S100A9
por: Möller, Alexander, et al.
Publicado: (2023)

S100A8 and S100A9 in experimental osteoarthritis
por: Zreiqat, Hala, et al.
Publicado: (2010)

S100A8/S100A9 Integrates F-Actin and Microtubule Dynamics to Prevent Uncontrolled Extravasation of Leukocytes
por: Wolf, Marc, et al.
Publicado: (2023)

Alarmin S100A8/S100A9 as a biomarker for molecular imaging of local inflammatory activity
por: Vogl, Thomas, et al.
Publicado: (2014)

Interleukin 17 Promotes Expression of Alarmins S100A8 and S100A9 During the Inflammatory Response of Keratinocytes
por: Christmann, Carolin, et al.
Publicado: (2021)

MMP-8 Deficiency Increases TLR/RAGE Ligands S100A8 and S100A9 and Exacerbates Lung Inflammation during Endotoxemia
por: González-López, Adrián, et al.
Publicado: (2012)

Emerging targets for cancer treatment: S100A9/RAGE
por: Valiente, M., et al.
Publicado: (2023)

The alarmins S100A8 and S100A9 mediate acute pain in experimental synovitis
por: Blom, Arjen B., et al.
Publicado: (2020)

S100A8/A9 is the first predictive marker for neonatal sepsis
por: Pirr, Sabine, et al.
Publicado: (2021)

S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes
por: Lin, Cindy, et al.
Publicado: (2023)

C/EBPδ-induced epigenetic changes control the dynamic gene transcription of S100a8 and S100a9
por: Jauch-Speer, Saskia-Larissa, et al.
Publicado: (2022)

S100A8/A9 and sRAGE kinetic after polytrauma; an explorative observational study
por: Joly, Philippe, et al.
Publicado: (2017)

Pro-Inflammatory S100A8 and S100A9 Proteins: Self-Assembly into Multifunctional Native and Amyloid Complexes
por: Vogl, Thomas, et al.
Publicado: (2012)

S100A9 extends lifespan in insulin deficiency
por: Ramadori, Giorgio, et al.
Publicado: (2019)

Transcriptome profiling of mouse colonic eosinophils reveals a key role for eosinophils in the induction of s100a8 and s100a9 in mucosal healing
por: Reichman , Hadar, et al.
Publicado: (2017)

S100A8 and S100A9 promote endothelial cell activation through the RAGE-mediated mammalian target of rapamycin complex 2 pathway
por: Zhong, Xiang, et al.
Publicado: (2020)

Alarming and Calming: Opposing Roles of S100A8/S100A9 Dimers and Tetramers on Monocytes
por: Russo, Antonella, et al.
Publicado: (2022)

Blocking the interaction between S100A9 protein and RAGE V domain using S100A12 protein
por: Katte, Revansiddha, et al.
Publicado: (2018)

The S100B/RAGE Axis in Alzheimer's Disease
por: Leclerc, Estelle, et al.
Publicado: (2010)

Serum alarmin S100A8/S100A9 levels and its potential role as biomarker in myocarditis
por: Müller, Irene, et al.
Publicado: (2020)

Author Correction: Transcriptome profiling of mouse colonic eosinophils reveals a key role for eosinophils in the induction of s100a8 and s100a9 in mucosal healing
por: Reichman, Hadar, et al.
Publicado: (2018)

S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain
por: Khan, Md. Imran, et al.
Publicado: (2018)

The phagocyte specific protein S100A12 as a novel biomarker in Muckle-Wells-Syndrome before and during therapy with Anakinra and Canakinumab (ACZ885)
por: Wittkowski, H, et al.
Publicado: (2008)

In vivo imaging of microenvironmental and anti-PD-L1-mediated dynamics in cancer using S100A8/S100A9 as an imaging biomarker
por: Helfen, Anne, et al.
Publicado: (2022)

S100B as an Antagonist To Interfere with the Interface Area Flanked by S100A11 and RAGE V Domain
por: Dowarha, Deepu, et al.
Publicado: (2018)

S100A4 inhibits cell proliferation by interfering with the S100A1-RAGE V domain
por: Khan, Md. Imran, et al.
Publicado: (2019)

S100A8, S100A9 and S100A8/A9 heterodimer as novel cachexigenic factors for pancreatic cancer-induced cachexia
por: Liao, Wei-Chih, et al.
Publicado: (2023)

S100A8/A9 and S100A9 reduce acute lung injury
por: Hiroshima, Yuka, et al.
Publicado: (2017)

Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism
por: Monteiro, Cátia, et al.
Publicado: (2022)

S100A8 & S100A9: Alarmin mediated inflammation in tendinopathy
por: Crowe, Lindsay A. N., et al.
Publicado: (2019)

Proteomic analysis of Systemic Sclerosis serum identifies the toll-like receptor agonists S100A8/A9 as a novel possible pathogenic marker
por: van Bon, L, et al.
Publicado: (2010)

The Damage Associated Molecular Pattern (DAMP) molecule S100A12 induces pro-inflammatory responses in monocytes via innate immunity signalling pathways
por: Wittkowski, H, et al.
Publicado: (2008)

Increased Plasma Levels of S100A8, S100A9, and S100A12 in Chronic Spontaneous Urticaria
por: Zhou, Qiong-Yan, et al.
Publicado: (2019)

Targeting RAGE in sepsis
por: van Zoelen, Marieke AD, et al.
Publicado: (2008)

S100A8 and S100A9 in Hematologic Malignancies: From Development to Therapy
por: Razmkhah, Farnaz, et al.
Publicado: (2023)

Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cells
por: Ma, Li, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h7k479ggpbb5phu89pcslpa97d